GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OTCPK:PHCUF) » Definitions » Price-to-Free-Cash-Flow

PhotoCure ASA (PhotoCure ASA) Price-to-Free-Cash-Flow : 34.80 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is PhotoCure ASA Price-to-Free-Cash-Flow?

As of today (2024-05-26), PhotoCure ASA's share price is $5.95. PhotoCure ASA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.17. Hence, PhotoCure ASA's Price-to-Free-Cash-Flow Ratio for today is 34.80.

The historical rank and industry rank for PhotoCure ASA's Price-to-Free-Cash-Flow or its related term are showing as below:

PHCUF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13   Med: 97.24   Max: 2657.78
Current: 32.68

During the past 13 years, PhotoCure ASA's highest Price-to-Free-Cash-Flow Ratio was 2657.78. The lowest was 13.00. And the median was 97.24.

PHCUF's Price-to-Free-Cash-Flow is ranked worse than
60.04% of 513 companies
in the Drug Manufacturers industry
Industry Median: 23.77 vs PHCUF: 32.68

PhotoCure ASA's Free Cash Flow per Share for the three months ended in Mar. 2024 was $0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.17.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of PhotoCure ASA was 732.90% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 33.00% per year.

During the past 13 years, PhotoCure ASA's highest 3-Year average Free Cash Flow per Share Growth Rate was 69.50% per year. The lowest was -81.00% per year. And the median was 14.00% per year.


PhotoCure ASA Price-to-Free-Cash-Flow Historical Data

The historical data trend for PhotoCure ASA's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Price-to-Free-Cash-Flow Chart

PhotoCure ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.89 189.01 137.85 - 50.79

PhotoCure ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.03 34.85 79.94 50.79 30.15

Competitive Comparison of PhotoCure ASA's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Price-to-Free-Cash-Flow falls into.



PhotoCure ASA Price-to-Free-Cash-Flow Calculation

PhotoCure ASA's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=5.95/0.171
=34.80

PhotoCure ASA's Share Price of today is $5.95.
PhotoCure ASA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

PhotoCure ASA  (OTCPK:PHCUF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


PhotoCure ASA Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA (PhotoCure ASA) Business Description

Traded in Other Exchanges
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, Netherlands, Other European countries, and the United States.